Zografos L, Wolin D, Andrews E, Calingaert B, Balabanova Y, Horvat-Brocker A, Tarenz C, Suzart-Woischnik K. Evaluating patient and physician knowledge of risks and safe use of rivaroxaban: a survey across four countries. Expert Opin Drug Saf. 2022 Mar;21(3):435-46. doi: 10.1080/14740338.2022.1998451
Gutierrez L, Roskell N, Castellsague J, Beard S, Rycroft C, Abeysinghe S, Shannon P, Gitlin M, Robbins S. Clinical burden and incremental cost of fractures in postmenopausal women in the United Kingdom. Bone. 2012 Sep 1;51(3):324-31.
Lavonas EJ, Fries JF, Furst DE, Rothman KJ, Stergachis A, Vaida AJ, Zelterman D, Reynolds KM, Green JL, Dart RC. Comparative risks of non-prescription analgesics: a structured topic review and research priorities. Expert Opin Drug Saf. 2012 Jan 1;11(1):33-44.
Kiel DP, Grazette L, Siddhanti S, Daizadeh N, Wang A, Anthony MS, Christiansen C. Effect of denosumab on 3-year progression of aortic calcification in postmenopausal women with osteoporosis at high risk of cardiovascular events. Poster presented at the 37th European Symposium on Calcified Tissues Conference; June 2010. Glasgow, Scotland. [abstract] Bone. 2010 Jun; 47(Suppl 1):S69. doi: 10.1016/j.bone.2010.04.134